Join Deft Research’s George Dippel and Rebellis Group’s Betsy Seals and John Selby as they present key findings from Deft’s 2022 Medicare...

Join Deft Research’s George Dippel and Rebellis Group’s Betsy Seals and John Selby as they present key findings from Deft’s 2022 Medicare...

For those of you who are new special needs plans effective January 1 of this year, you are very familiar with the new NCQA/CMS Face to...

Under the Consolidated Appropriations Act (CAA) 2021 On July 9, 2021, President Biden issued Executive Order 14036, “Promoting...

Co-Authored by Debra Devereaux and Roxanne Newland CY2023 Medication Advantage and Part D Proposed Rule (CMS-4192-P) Proposed provisions...

Betsy Seals, CEO of the Rebellis Group Updated: Dec 9, 2021 B-Time with Beth Bierbower on Apple Podcasts To help us understand what...

Part D Rejected Claims Review Co-Authored by Debra Devereaux and Roxanne Newland Where Medicare programs are concerned, no platitude...

Under the Consolidated Appropriations Act (CAA) 2021 On July 9, 2021, President Biden issued Executive Order 14036, “Promoting...

Co-Authored by Debra Devereaux and Roxanne Newland Proposed provisions in this rule will reduce out-of-pocket prescription drug costs,...

Now that the Annual Election Period (AEP) dust has settled, it is important to ensure that we’re reflecting on our performance in the...

B-Time with Beth Bierbower on Apple Podcasts To help us understand what Medicare Advantage plans are currently doing to attract and...

Anyone who has had the pleasure of navigating the Sales and Marketing Compliance realm this past year has experienced a brand-new...

"Like many people, I ended up in Medicare Advantage by happenstance. I was in my second year of college, and I got a job in Customer...